Abhay Joshi
2016
In 2016, Abhay Joshi earned a total compensation of $1.4M as Chief Operating Officer at Revance Therapeutics, a 75% decrease compared to previous year.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Non-Equity Incentive Plan | $160,875 |
| Salary | $440,000 |
| Stock Awards | $606,600 |
| Total | $1,407,475 |
Joshi received $606.6K in stock awards, accounting for 43% of the total pay in 2016.
Joshi also received $200K in bonus, $160.9K in non-equity incentive plan and $440K in salary.
Rankings
In 2016, Abhay Joshi's compensation ranked 6,568th out of 14,075 executives tracked by ExecPay. In other words, Joshi earned more than 53.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,568 out of 14,075 | 53rd |
Division Manufacturing | 2,430 out of 5,486 | 56th |
Major group Chemicals And Allied Products | 792 out of 1,900 | 58th |
Industry group Drugs | 606 out of 1,543 | 61st |
Industry Pharmaceutical Preparations | 477 out of 1,173 | 59th |
Source: SEC filing on March 24, 2017.
Joshi's colleagues
We found two more compensation records of executives who worked with Abhay Joshi at Revance Therapeutics in 2016.
News
Revance Therapeutics CEO Mark Foley's 2021 pay slips 19% to $7.1M
March 24, 2022
Revance Therapeutics CEO Mark Foley's 2020 pay falls 49% to $8.8M
March 11, 2021
Revance Therapeutics CEO Mark Foley receives $17M in 2019
March 26, 2020
Revance Therapeutics CEO L Browne's 2018 pay jumps 37% to $4.7M
March 25, 2019